Active substance
Tick borne encephalitis vaccine
- WHO EML 1
- Safety 2
WHO WHO Model List of Essential Medicines (2025)
- 19.3. Immunologicals > Vaccines · core
Need for immunization against arthropod-borne viral encephalitis
All vaccines should comply with the WHO requirements for biological substances.
Safety signals and safety-related labeling changes
- EMA PRAC 9 Jun 2017 PRAC signal: Potential vaccination failure in children
Action for MAH: update of the product information: No - EMA PRAC 9 Feb 2017 PRAC signal: Potential vaccination failure in children
Action for MAH: update of the product information: No
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.